Annual FCF
-$115.93 M
-$111.62 M-2590.44%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual free cash flow is -$115.93 million, with the most recent change of -$111.62 million (-2590.44%) on December 31, 2023.
- During the last 3 years, STRO annual FCF has fallen by -$41.00 million (-54.72%).
- STRO annual FCF is now -1141.98% below its all-time high of $11.13 million, reached on December 31, 2018.
Performance
STRO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$65.34 M
-$74.04 M-851.17%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly free cash flow is -$65.34 million, with the most recent change of -$74.04 million (-851.17%) on September 30, 2024.
- Over the past year, STRO quarterly FCF has dropped by -$77.97 million (-617.33%).
- STRO quarterly FCF is now -200.35% below its all-time high of $65.12 million, reached on September 30, 2022.
Performance
STRO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$109.20 M
-$31.51 M-40.57%
September 30, 2024
Summary
- As of February 7, 2025, STRO TTM free cash flow is -$109.20 million, with the most recent change of -$31.51 million (-40.57%) on September 30, 2024.
- Over the past year, STRO TTM FCF has increased by +$6.73 million (+5.81%).
- STRO TTM FCF is now -711.46% below its all-time high of $17.86 million, reached on September 30, 2018.
Performance
STRO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
STRO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2590.4% | -617.3% | +5.8% |
| 3 y3 years | -54.7% | -617.3% | +5.8% |
| 5 y5 years | -1142.0% | -617.3% | +5.8% |
STRO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2590.4% | at low | -200.3% | at low | -9038.2% | +29.9% |
| 5 y | 5-year | -2590.4% | at low | -200.3% | at low | -9038.2% | +29.9% |
| alltime | all time | -1142.0% | at low | -200.3% | at low | -711.5% | +29.9% |
Sutro Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$65.34 M(-851.2%) | -$109.20 M(+40.6%) |
| Jun 2024 | - | $8.70 M(-113.3%) | -$77.69 M(-34.8%) |
| Mar 2024 | - | -$65.19 M(-616.1%) | -$119.19 M(+2.8%) |
| Dec 2023 | -$115.93 M(+2590.4%) | $12.63 M(-137.3%) | -$115.93 M(-25.6%) |
| Sep 2023 | - | -$33.83 M(+3.1%) | -$155.79 M(+174.1%) |
| Jun 2023 | - | -$32.80 M(-47.0%) | -$56.85 M(+93.1%) |
| Mar 2023 | - | -$61.93 M(+127.4%) | -$29.43 M(+583.1%) |
| Dec 2022 | -$4.31 M(-95.6%) | -$27.23 M(-141.8%) | -$4.31 M(+260.6%) |
| Sep 2022 | - | $65.12 M(-1309.0%) | -$1.20 M(-98.8%) |
| Jun 2022 | - | -$5.39 M(-85.4%) | -$95.71 M(-5.2%) |
| Mar 2022 | - | -$36.81 M(+52.6%) | -$101.00 M(+4.1%) |
| Dec 2021 | -$97.00 M | -$24.12 M(-18.0%) | -$97.00 M(+3.9%) |
| Sep 2021 | - | -$29.40 M(+175.4%) | -$93.39 M(+10.3%) |
| Jun 2021 | - | -$10.68 M(-67.5%) | -$84.65 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$32.81 M(+60.0%) | -$88.24 M(+17.8%) |
| Dec 2020 | -$74.93 M(+9.4%) | -$20.50 M(-0.8%) | -$74.93 M(+7.6%) |
| Sep 2020 | - | -$20.66 M(+44.8%) | -$69.63 M(+5.9%) |
| Jun 2020 | - | -$14.27 M(-26.8%) | -$65.76 M(-2.7%) |
| Mar 2020 | - | -$19.50 M(+28.2%) | -$67.58 M(-1.3%) |
| Dec 2019 | -$68.50 M(-715.7%) | -$15.21 M(-9.4%) | -$68.50 M(+14.1%) |
| Sep 2019 | - | -$16.79 M(+4.3%) | -$60.03 M(-1612.1%) |
| Jun 2019 | - | -$16.09 M(-21.2%) | $3.97 M(-34.7%) |
| Mar 2019 | - | -$20.42 M(+203.3%) | $6.08 M(-45.4%) |
| Dec 2018 | $11.13 M(-127.5%) | -$6.73 M(-114.3%) | $11.13 M(-37.7%) |
| Sep 2018 | - | $47.21 M(-437.7%) | $17.86 M(-160.8%) |
| Jun 2018 | - | -$13.98 M(-9.1%) | -$29.36 M(+90.9%) |
| Mar 2018 | - | -$15.37 M | -$15.37 M |
| Dec 2017 | -$40.39 M(+130.2%) | - | - |
| Dec 2016 | -$17.55 M | - | - |
FAQ
- What is Sutro Biopharma annual free cash flow?
- What is the all time high annual FCF for Sutro Biopharma?
- What is Sutro Biopharma annual FCF year-on-year change?
- What is Sutro Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Sutro Biopharma?
- What is Sutro Biopharma quarterly FCF year-on-year change?
- What is Sutro Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Sutro Biopharma?
- What is Sutro Biopharma TTM FCF year-on-year change?
What is Sutro Biopharma annual free cash flow?
The current annual FCF of STRO is -$115.93 M
What is the all time high annual FCF for Sutro Biopharma?
Sutro Biopharma all-time high annual free cash flow is $11.13 M
What is Sutro Biopharma annual FCF year-on-year change?
Over the past year, STRO annual free cash flow has changed by -$111.62 M (-2590.44%)
What is Sutro Biopharma quarterly free cash flow?
The current quarterly FCF of STRO is -$65.34 M
What is the all time high quarterly FCF for Sutro Biopharma?
Sutro Biopharma all-time high quarterly free cash flow is $65.12 M
What is Sutro Biopharma quarterly FCF year-on-year change?
Over the past year, STRO quarterly free cash flow has changed by -$77.97 M (-617.33%)
What is Sutro Biopharma TTM free cash flow?
The current TTM FCF of STRO is -$109.20 M
What is the all time high TTM FCF for Sutro Biopharma?
Sutro Biopharma all-time high TTM free cash flow is $17.86 M
What is Sutro Biopharma TTM FCF year-on-year change?
Over the past year, STRO TTM free cash flow has changed by +$6.73 M (+5.81%)